
Basaglar Side Effects: Common, Severe, Long Term - Drugs.com
Nov 21, 2025 · Learn about the side effects of Basaglar (insulin glargine), from common to rare, for consumers and healthcare professionals.
Symbravo: Uses, Dosage, Side Effects, Warnings - Drugs.com
Jul 30, 2025 · Symbravo is used to treat acute migraine headaches with or without aura in adults. It is a combination tablet that is taken once a day. Symbravo contains meloxicam and rizatriptan. Includes …
Meloxicam and rizatriptan - Drugs.com
Dec 3, 2025 · Meloxicam/rizatriptan is a combination tablet used to treat acute migraines with or without aura in adults. It is an FDA-approved prescription medication that treats migraines that have begun, …
Relpax: Package Insert / Prescribing Information / MOA
Jul 7, 2025 · Relpax package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Zolmitriptan: Package Insert / Prescribing Information / MOA
Jul 10, 2024 · Zolmitriptan package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Dihydroergotamine Injection: Package Insert / Prescribing Info
Mar 2, 2025 · Dihydroergotamine Injection package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
RizaFilm: Uses, Dosage, Side Effects & Warnings - Drugs.com
RizaFilm (rizatriptan) is an oral film formulation of the triptan drug rizatriptan indicated for the acute treatment of migraine. Includes RizaFilm side effects, interactions and indications.
Rizatriptan Monograph for Professionals - Drugs.com
Jul 28, 2025 · Rizatriptan reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).
CGRP Inhibitors & Antagonist Drugs List - Drugs.com
May 17, 2018 · Browse CGRP inhibitor drugs, compare monoclonal antibodies and gepant antagonists, see brand/generic names, migraine uses, user ratings and safety info.
D.H.E. 45: Package Insert / Prescribing Information / MOA
May 7, 2025 · D.H.E. 45 (dihydroergotamine mesylate) Injection, USP should not be administered to patients with hemiplegic or basilar migraine. In addition to those conditions mentioned above, D.H.E. …